FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,097,000 | -6.3% | 451,869 | 0.0% | 0.19% | +5.0% |
| Q1 2017 | $2,237,000 | -48.3% | 451,869 | +16.0% | 0.18% | -54.1% |
| Q4 2016 | $4,324,000 | -9.0% | 389,586 | -24.1% | 0.39% | +37.8% |
| Q3 2016 | $4,750,000 | +214.4% | 512,995 | +115.5% | 0.28% | +139.8% |
| Q2 2016 | $1,511,000 | -2.6% | 237,995 | 0.0% | 0.12% | +35.6% |
| Q1 2016 | $1,552,000 | -19.6% | 237,995 | 0.0% | 0.09% | -25.6% |
| Q4 2015 | $1,930,000 | – | 237,995 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |